<SEC-DOCUMENT>0001104659-19-012883.txt : 20190305
<SEC-HEADER>0001104659-19-012883.hdr.sgml : 20190305
<ACCEPTANCE-DATETIME>20190305164044
ACCESSION NUMBER:		0001104659-19-012883
CONFORMED SUBMISSION TYPE:	IRANNOTICE
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20190305
DATE AS OF CHANGE:		20190305

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ASTRAZENECA PLC
		CENTRAL INDEX KEY:			0000901832
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		IRANNOTICE
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11960
		FILM NUMBER:		19659033

	BUSINESS ADDRESS:	
		STREET 1:		1 FRANCIS CRICK AVENUE
		STREET 2:		CAMBRIDGE BIOMEDICAL CAMPUS
		CITY:			CAMBRIDGE
		STATE:			X0
		ZIP:			CB2 0AA
		BUSINESS PHONE:		011 44 20 7304 5000

	MAIL ADDRESS:	
		STREET 1:		1 FRANCIS CRICK AVENUE
		STREET 2:		CAMBRIDGE BIOMEDICAL CAMPUS
		CITY:			CAMBRIDGE
		STATE:			X0
		ZIP:			CB2 0AA

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZENECA GROUP PLC
		DATE OF NAME CHANGE:	19930422
</SEC-HEADER>
<DOCUMENT>
<TYPE>IRANNOTICE
<SEQUENCE>1
<FILENAME>a19-3601_3irannotice.htm
<DESCRIPTION>IRANNOTICE
<TEXT>


<html>
<head>







  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="228" height="64" src="g36013bgi001.jpg"></font></p>    </td>   </tr>
<tr>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">AstraZeneca   PLC</font></p>    </td>   </tr>
<tr>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1   Francis Crick Avenue</font></p>    </td>   </tr>
<tr>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cambridge   Biomedical Campus</font></p>    </td>   </tr>
<tr>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cambridge,   CB2 0AA</font></p>    </td>   </tr>
<tr>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">United   Kingdom</font></p>    </td>   </tr>
<tr>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">T:   +44 (0) 20 3749 5000</font></p>    </td>   </tr>
<tr>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">astrazeneca.com</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">U.S. Securities and Exchange Commission<br> 100 F Street, N.E.<br> Washington, D.C. 20549</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">March&nbsp;5, </font>2019</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.56%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Re:</font></b></p>    </td>
<td width="94%" valign="top" style="padding:0in 0in 0in 0in;width:94.44%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Notice   of disclosure filed in Exchange Act Annual Report under Section&nbsp;219 of   the Iran Threat Reduction and Syria Human Rights Act of 2012 and   Section&nbsp;13(r)&nbsp;of the Exchange Act</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen,</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to Section&nbsp;219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section&nbsp;13(r)&nbsp;of the Securities Exchange Act of 1934, as amended, notice is hereby provided that AstraZeneca PLC has made disclosure pursuant to those provisions in its Annual Report on Form&nbsp;20-F for the year ended December&nbsp;31, 2018, which was filed with the Securities and Exchange Commission on </font>March&nbsp;5, 2019. The disclosure can be found under the heading &#147;Item&nbsp;4.B Business Overview&#151;Disclosures Under the Iran Threat Reduction and Syria Human Rights Act of 2012&#148; in the Annual Report on Form&nbsp;20-F.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Respectfully submitted,</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="48%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ A C N Kemp</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">A C N Kemp</font></b></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Authorized Signatory</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">AstraZeneca PLC</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">AstraZeneca PLC</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registered in England   No. 2723534</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registered office: 1   Francis Crick Avenue</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cambridge Biomedical   Campus</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cambridge, CB2 0AA</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">United Kingdom</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109764\19-3601-3\task9244780\3601-3-bg.htm',USER='109764',CD='Mar  5 22:39 2019' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g36013bgi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g36013bgi001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !  .0# 2(  A$! Q$!_\0
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M=,-AZ(ISGZFNCCC2) D:A5'0"KP^!JXJJL3B-.R%4KPI0]E3U'44M%?0'GG
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MBVW>WYG!Z!>6?BGQ-)X@\07UK!!;MMM+6691C'0D$]OU->A#Q+HI/&K6.?\
MKX7_ !K*_P"%;>&/^@:/^_K_ .- ^&_A@$$::,CG_6/_ (T-Q8JLZ-1[NWR.
M3M+#2K'XDZG:>(+:WDAOOWMK)<*"O)SP3ZYQ^%=-J>G^"-'\K[=9:;&96VHH
MB#$_@.:W-5\/:9K=LD&HVB3(GW">&7Z$<BJ.F>!=!TFZ6YMK+,R\J\KEROTR
M>*.:XG7C*S;:?D<W=PPVWQ@T2&VC6.%+(A$48"C:^!BNJ\9?\B=JW_7L_P#*
MK4NAV$VM1:M)!F^A38DNX\#GMT[FK-[9PZA9RVMRF^&92CKG&0:3>Q$JJ<H/
MM8\<NK1(/#GA'5[JW$]C#NBN$9<C!<GG]:] ;1_!::<;\V6E?9=N[S-BXQ_C
M[5N0:+86VDKIB6R&R52ODO\ ,,$Y[UB+\-O#2S>9]@)&<[#*Q3\LXIN29K+$
M1GNVM]CG_%NDZ7J?@%[SPQ;1+ DHF80Q%-P'!.,<XKK/#'B.QUC0+:>.XB#K
M&%E0N 4(&#FMF*"*"!88HT2)1M5%& !Z8KG;OX>>'+RY:=[#8['+"*1D!_ '
M%*Z:LS/VL)QY9WWT>YF^+O&4,WAC4FT"Z+W%NZQ2R1@_NP3@D'I[9JCX;\/^
M$1H$&I:C-;W<SQAYI+F;.&QDC:3VKM[/0M-L-.:PMK.%+5AAX]N0WU]:QX_A
MUX:BNA.NG D'(1G8IG_=SBFFK6*C6IQBXJZU^\Y?X;3VUQXUUR2RB$-LZ9B0
M+MPNX8X^E>BZC=_8K&28#+ 8 ]ZKVGA_3K'5I]2MK<1W4ZA)&5C@CCMT["K\
MT*3QM'*H9&X(-95N:46H.SMH15JQJ5%*VFAP<LKSRM)*Q9F.236I8ZG8Z>G[
MNV>20CEV(S6M_P (Y8[L[7QZ;JL1:/8P\K;H3ZMS_.OG</E>+I3<^97[[G54
MQ5*4>6S_ ",*&]FENP^EVSQ[C\Z9RA_PKJ1G SUH50@PH 'L*=7LX7#RH)\T
3KW^2^2.*K44[65@HHHKK,C__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
